These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16202775)

  • 1. Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.
    Dankert-Roelse JE; Mérelle ME
    J Pediatr; 2005 Sep; 147(3 Suppl):S15-20. PubMed ID: 16202775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!
    Farrell PM; Lai HJ; Li Z; Kosorok MR; Laxova A; Green CG; Collins J; Hoffman G; Laessig R; Rock MJ; Splaingard ML
    J Pediatr; 2005 Sep; 147(3 Suppl):S30-6. PubMed ID: 16202779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of newborn screening for cystic fibrosis on pulmonary outcomes in new South Wales.
    McKay KO; Waters DL; Gaskin KJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S47-50. PubMed ID: 16202782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of published evidence on outcomes with early diagnosis from large US observational studies.
    Rosenfeld M
    J Pediatr; 2005 Sep; 147(3 Suppl):S11-4. PubMed ID: 16202774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications associated with symptomatic diagnosis in infants with cystic fibrosis.
    Accurso FJ; Sontag MK; Wagener JS
    J Pediatr; 2005 Sep; 147(3 Suppl):S37-41. PubMed ID: 16202780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.
    Koscik RL; Lai HJ; Laxova A; Zaremba KM; Kosorok MR; Douglas JA; Rock MJ; Splaingard ML; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S51-6. PubMed ID: 16202783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life of children with cystic fibrosis.
    Koscik RL; Douglas JA; Zaremba K; Rock MJ; Splaingard ML; Laxova A; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S64-8. PubMed ID: 16202786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany).
    Siret D; Bretaudeau G; Branger B; Dabadie A; Dagorne M; David V; de Braekeleer M; Moisan-Petit V; Picherot G; Rault G; Storni V; Roussey M
    Pediatr Pulmonol; 2003 May; 35(5):342-9. PubMed ID: 12687590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal screening for cystic fibrosis is beneficial even in the context of modern treatment.
    Sims EJ; McCormick J; Mehta G; Mehta A;
    J Pediatr; 2005 Sep; 147(3 Suppl):S42-6. PubMed ID: 16202781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The survival advantage of patients with cystic fibrosis diagnosed through neonatal screening: evidence from the United States Cystic Fibrosis Foundation registry data.
    Lai HJ; Cheng Y; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S57-63. PubMed ID: 16202784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions.
    Wilfond BS; Parad RB; Fost N
    J Pediatr; 2005 Sep; 147(3 Suppl):S109-13. PubMed ID: 16202773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding newborn screening system issues with emphasis on cystic fibrosis screening.
    Therrell BL; Lloyd-Puryear MA; Mann MY
    J Pediatr; 2005 Sep; 147(3 Suppl):S6-10. PubMed ID: 16202785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth in prepubertal children with cystic fibrosis, homozygous for the Delta F508 mutation.
    Keller BM; Aebischer CC; Kraemer R; Schöni MH
    J Cyst Fibros; 2003 Jun; 2(2):76-83. PubMed ID: 15463854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newborn screening for cystic fibrosis: an opportunity to improve care and outcomes.
    Campbell PW; White TB
    J Pediatr; 2005 Sep; 147(3 Suppl):S2-5. PubMed ID: 16202776
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of body mass index percentiles for assessment of malnutrition in children with cystic fibrosis.
    Wiedemann B; Paul KD; Stern M; Wagner TO; Hirche TO;
    Eur J Clin Nutr; 2007 Jun; 61(6):759-68. PubMed ID: 17213872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal pulmonary status of cystic fibrosis children with meconium ileus.
    Li Z; Lai HJ; Kosorok MR; Laxova A; Rock MJ; Splaingard ML; Farrell PM
    Pediatr Pulmonol; 2004 Oct; 38(4):277-84. PubMed ID: 15334503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.
    Padman R; McColley SA; Miller DP; Konstan MW; Morgan WJ; Schechter MS; Ren CL; Wagener JS;
    Pediatrics; 2007 Mar; 119(3):e531-7. PubMed ID: 17332172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.